9月24日，麦迪科技盘中上涨2.34%，截至13:03，报14.45元/股，成交5340.48万元，换手率1.23%，总市 值44.26亿元。 截至6月30日，麦迪科技股东户数3.63万，较上期减少24.87%；人均流通股8429股，较上期增加 33.09%。2025年1月-6月，麦迪科技实现营业收入1.35亿元，同比减少47.24%；归母净利润2832.75万 元，同比增长137.11%。 分红方面，麦迪科技A股上市后累计派现7135.67万元。近三年，累计派现0.00元。 机构持仓方面，截止2025年6月30日，麦迪科技十大流通股东中，鹏华碳中和主题混合A（016530）位 居第八大流通股东，持股219.36万股，为新进股东。 责任编辑：小浪快报 今年以来麦迪科技已经8次登上龙虎榜，最近一次登上龙虎榜为3月10日，当日龙虎榜净买入3115.92万 元；买入总计1.15亿元 ，占总成交额比8.31%；卖出总计8361.32万元 ，占总成交额比6.06%。 资料显示，苏州麦迪斯顿医疗科技股份有限公司位于江苏省苏州工业园区归家巷222号，成立日期2009 年8月14日，上市日期2016年12月8日，公司主营业务 ...

Core Viewpoint - The stock of Weining Health has shown fluctuations in recent trading sessions, with a notable increase of 2.05% on September 24, 2023, while the company faces a significant decline in revenue and profit for the first half of 2025 [1][2]. Group 1: Stock Performance - As of September 24, 2023, Weining Health's stock price reached 8.96 CNY per share, with a market capitalization of 19.836 billion CNY [1]. - The stock has increased by 25.40% year-to-date, but has seen declines of 4.38% over the last five trading days, 15.39% over the last twenty days, and 10.22% over the last sixty days [1]. Group 2: Financial Performance - For the first half of 2025, Weining Health reported a revenue of 839 million CNY, a decrease of 31.43% year-on-year, and a net profit of -118 million CNY, representing a decline of 491.04% [2]. - The company has distributed a total of 455 million CNY in dividends since its A-share listing, with 97.226 million CNY distributed over the last three years [3]. Group 3: Shareholder Information - As of September 19, 2023, the number of Weining Health's shareholders was 117,800, a decrease of 0.53% from the previous period, while the average number of circulating shares per person increased by 0.53% to 16,244 shares [2]. - The top three circulating shareholders include Huabao Zhongzheng Medical ETF, which increased its holdings by 1.7506 million shares, and Yifangda Growth Enterprise ETF, which decreased its holdings by 652,300 shares [3].

资料显示，重庆山外山血液净化技术股份有限公司位于重庆市两江新区慈济路1号，成立日期2001年3月 26日，上市日期2022年12月26日，公司主营业务涉及血液净化设备的研发、生产和销售。主营业务收入 构成为：血液净化设备66.12%，血液净化耗材23.89%，医疗服务8.31%，其他1.68%。 山外山所属申万行业为：医药生物-医疗器械-医疗设备。所属概念板块包括：医用耗材、智慧医疗、小 盘、医疗器械、专精特新等。 截至6月30日，山外山股东户数8150.00，较上期增加2.67%；人均流通股28779股，较上期减少2.60%。 2025年1月-6月，山外山实现营业收入3.57亿元，同比增长28.72%；归母净利润5503.86万元，同比增长 20.28%。 9月24日，山外山盘中上涨2.16%，截至10:56，报14.66元/股，成交2120.38万元，换手率0.63%，总市值 47.10亿元。 资金流向方面，主力资金净流入24.80万元，大单买入77.10万元，占比3.64%，卖出52.31万元，占比 2.47%。 山外山今年以来股价涨32.55%，近5个交易日跌2.66%，近20日跌5.84%，近60日 ...

Core Viewpoint - The stock of Electric Broad Media has shown a significant increase in price and trading volume, indicating positive market sentiment despite some net outflow of funds [1][2]. Company Overview - Electric Broad Media, established on January 26, 1999, and listed on March 25, 1999, is based in Changsha, Hunan Province. The company specializes in various media-related services, including advertising, film production, e-commerce, and investment management [1][2]. - The company's revenue composition includes: advertising operations (65.66%), investment management (12.73%), gaming (12.50%), tourism (5.87%), hotel services (3.29%), art (0.03%), film production and distribution (0.02%), and real estate (0.01%) [1]. Financial Performance - As of June 30, 2025, Electric Broad Media reported a revenue of 1.968 billion yuan, representing a year-on-year growth of 9.45%. However, the net profit attributable to shareholders decreased by 41.84% to 40.698 million yuan [2]. - The company has distributed a total of 695 million yuan in dividends since its A-share listing, with 85.0534 million yuan distributed over the past three years [3]. Shareholder Information - As of June 30, 2025, the number of shareholders decreased by 3.28% to 89,700, while the average circulating shares per person increased by 3.40% to 15,797 shares [2]. - Among the top ten circulating shareholders, notable changes include an increase in holdings by the Southern CSI 1000 ETF and a decrease by Hong Kong Central Clearing Limited [3].

Core Viewpoint - He Eye Hospital's stock price has experienced fluctuations, with a year-to-date increase of 2.14% but a significant decline in recent trading periods, indicating potential volatility in investor sentiment [2]. Company Overview - He Eye Hospital Group, established on October 15, 2009, and listed on March 22, 2022, is located in Shenyang, Liaoning Province. The company specializes in providing ophthalmic specialty diagnosis and treatment services [2]. - The revenue composition of He Eye Hospital includes: Vision services (30.24%), Refractive surgery correction services (24.16%), Non-surgical treatments (20.02%), Cataract diagnosis and treatment services (13.68%), Vitreoretinal diagnosis and treatment services (8.09%), Other ophthalmic diagnosis and treatment services (3.20%), and Other business income (0.61%) [2]. Financial Performance - As of June 30, 2025, He Eye Hospital reported a revenue of 560 million yuan, a year-on-year decrease of 4.22%. However, the net profit attributable to shareholders was 44.32 million yuan, reflecting a significant year-on-year increase of 84.19% [2]. - The company has distributed a total of 348 million yuan in dividends since its A-share listing, with 275 million yuan distributed over the past three years [3]. Shareholder Information - As of June 30, 2025, the number of shareholders for He Eye Hospital was 10,800, an increase of 15.03% from the previous period. The average circulating shares per person decreased by 13.07% to 7,684 shares [2]. - Among the top ten circulating shareholders, the Rongtong Health Industry Flexible Allocation Mixed A/B fund held 2.7947 million shares, a decrease of 1.7584 million shares compared to the previous period [3].

Company Overview - Xiamen Dineike Intelligent Technology Co., Ltd. was established on April 29, 2005, and listed on November 12, 2020. The company specializes in the research, design, production, and sales of smart community security equipment, including intercom systems and smart home products [2] - The main revenue composition includes: intercom products 51.99%, smart home products 22.44%, smart ward and outpatient products 13.13%, and others 12.44% [2] - Dineike belongs to the Shenwan industry classification of computer-computer equipment-security equipment and is involved in concepts such as smart parking, smart healthcare, elderly care industry, express delivery, and facial recognition [2] Financial Performance - As of July 31, the number of shareholders is 23,500, a decrease of 15.52% from the previous period, with an average of 8,154 circulating shares per person, an increase of 18.37% [2] - For the first half of 2025, Dineike reported operating revenue of 284 million yuan, a year-on-year decrease of 14.53%, and a net profit attributable to shareholders of -2.23 million yuan, a year-on-year decrease of 108.58% [2] Stock Performance - On September 22, Dineike's stock price increased by 2.12%, reaching 13.47 yuan per share, with a trading volume of 65.79 million yuan and a turnover rate of 2.60%, resulting in a total market capitalization of 3.42 billion yuan [1] - Year-to-date, Dineike's stock price has risen by 20.48%, with a 0.37% increase over the last five trading days, an 8.55% decrease over the last 20 days, and a 0.37% increase over the last 60 days [1] - Dineike has appeared on the "Dragon and Tiger List" three times this year, with the most recent appearance on May 9, where the net buying on that day was -6.83 million yuan, with total buying of 66.62 million yuan (7.95% of total trading volume) and total selling of 73.46 million yuan (8.76% of total trading volume) [1] Dividend Information - Since its A-share listing, Dineike has distributed a total of 197 million yuan in dividends, with 137 million yuan distributed over the past three years [3]

Core Viewpoint - The new medical model of "community first diagnosis + one-stop appointment" is becoming a daily health routine for 690,000 residents in Changning District, aiming to enhance healthcare efficiency and accessibility through integrated data systems and smart platforms [1][2]. Group 1: Smart Medical Services - Changning District promotes a "nearby, quick, and good" principle by integrating quality medical resources from various institutions, enabling patients to complete necessary medical evaluations with minimal visits [2]. - The introduction of a one-stop intelligent anesthesia risk assessment system and gastrointestinal examination services allows patients to book appointments online through family doctors, with results shared in real-time [2]. - An AI-driven intelligent report interpretation system has been developed to explain medical reports in simple language, while a big data-based health management system offers personalized health advice [2]. Group 2: Comprehensive Health Database - Changning District is building a comprehensive health database that tracks residents' health information throughout their lives, creating a real-time "health map" accessible to healthcare providers [3]. Group 3: Enhanced Efficiency for Healthcare Providers - The implementation of a smart unified desktop has streamlined operations for healthcare workers, reducing redundant tasks by over 30% and allowing for more focus on patient care [4]. - High-quality data management enables healthcare professionals to quickly access complete patient records, improving diagnostic accuracy and treatment effectiveness [4]. - The integration of patient data facilitates remote consultations between family doctors and specialists, enhancing collaboration and resource utilization [4]. Group 4: Data Management and Quality Assurance - Changning District has established a dual-track data standard system covering both clinical and public health data, creating 45 clinical data sets and 168 public health data sets to ensure data quality [5]. - A total of 7.9 billion clinical data entries and 1.59 billion public health data entries have been efficiently cleaned, achieving a data completeness rate of 91.32% [5]. Group 5: Future Innovations - Future plans include expanding data coverage and innovating applications such as AI health summaries and AI-assisted diagnosis to further enhance the quality and efficiency of medical services [6].

Group 1 - The company held a performance briefing on September 19, addressing various investor concerns related to information technology in small cities, smart inspection robots, changes in actual controllers, AI research and development investments, and the contract amounts for smart medical projects [1][2] - In terms of information technology needs in small cities, the company aims to achieve system interconnectivity through cloud platforms, constructing various platforms for hospitals, regions, and health care, while also engaging in carbon consulting and digital energy services [1] - The smart inspection robot, which was accepted in 2019, is designed to replace workers in inspection and facility management, but it has not yet been put into production and has not impacted the company's revenue [1] Group 2 - The company clarified that there are currently no controlling shareholders or actual controllers, and there are no clear plans for asset injection or restructuring at this time [2] - In the field of artificial intelligence, the company has developed a series of cloud platform products for smart city management and smart buildings, and its AI medical assistant "Xingzai" has upgraded medical services [2] - The contract amounts for the company's smart medical projects have remained stable over the past three years, maintaining long-term cooperation with key clients through optimized products and services [2]

Group 1: Company Overview and Business Segments - The company focuses on three main business areas: smart cities and cloud platforms, smart healthcare and big health, and green dual carbon and digital energy [1][2] - It provides full lifecycle information solutions, from top-level design to platform operation in the smart city sector [2] Group 2: Product Development and Innovation - The intelligent inspection robot for buildings, developed and accepted in 2019, is designed to replace manual inspections and manage facilities, but has not yet been put into production [3] - The company is leveraging artificial intelligence in smart city operations and healthcare, with projects like the AI medical assistant "Xingzai" to enhance data utilization and decision-making [3][4] Group 3: Financial Performance and Client Relationships - The signing amount for smart healthcare projects has remained stable over the past three years, indicating strong client retention and satisfaction [4] - The company continuously optimizes its products and services to deepen relationships with core clients in the healthcare sector [4] Group 4: Future Plans and Collaborations - Currently, there are no specific plans to develop new robots or large models in the fields of smart healthcare and elderly services [5] - There is no ongoing project collaboration with Huawei in AI healthcare, although potential future cooperation is acknowledged [6]

Core Insights - The company held a mid-year performance briefing on September 19, 2023, as part of the collective reception day for listed companies in Shanghai [1] - The company's executive president, Tang Wenyuan, highlighted the functionality of the intelligent inspection robot designed to replace human workers in inspection and facility management, focusing on routine inspections, data collection, and safety alarms [1] - The intelligent inspection robot project was completed in 2019 but has not yet been put into production or contributed to the company's revenue [1] Business Strategy - The company positions itself as a comprehensive provider of "smart city, smart healthcare construction, operation, and services," focusing on three main business segments: smart healthcare and wellness, smart cities and cloud platforms, and green dual-carbon and digital energy [1] - The company aims to provide "safe, intelligent, green, and healthy" lifecycle construction, operation, and management services [1]